PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

CD&R is nearing a deal to acquire control of Sanofi’s consumer health unit after it signed social commitments with the French ...

Sanofi said on Monday (Oct 21) it had entered exclusive talks for the sale of a 50 per cent controlling stake in its consumer ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...

Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...

PAI partners has submitted an improved bid for Sanofi’s consumer health business, in an attempt to re-enter the race for what ...

Donald Berwick, who ran Medicare during the Obama administration, says Medicare Advantage plans run by private insurers need a lot more regulation. He suggests a two-pronged system fix that would take ...

In its revised bid, PAI pledged to preserve headcount and raise investments at Opella's French production sites of Lisieux in Normandy and Compiegne, the source said. It also vowed to keep Opella's ...